US2021214305A1PendingUtilityA1
Composition and methods for modulating a kinase cascade
Est. expiryAug 30, 2032(~6.1 yrs left)· nominal 20-yr term from priority
Inventors:David G. Hangauer, Jr.
A61P 35/00A61P 25/28A61P 37/02A61P 43/00A61P 37/00C07C 303/32A61P 37/06A61P 19/10A61P 3/10A61P 27/16C07D 213/56C07C 309/29A61P 3/04A61P 9/00
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to compounds and methods for modulating one or more components of a kinase cascade. The invention also relates to substantially pure compound 1 and substantially pure compound 1 salt (e.g., compound 1 hydrochloride salt and compound 1 benzenesulfonate salt). The invention further relates to methods of preparing substantially pure compound 1 and compound 1 salts.
Claims
exact text as granted — not AI-modified1 . A benzenesulfonate salt of compound 1:
or a pharmaceutically acceptable salt or solvate thereof, prepared by a process comprising Step 3:
converting compound 12 to compound 1:
2 . The benzenesulfonate salt of claim 1 , wherein the process further comprises Step 2:
converting compound 11 to compound 12:
3 . The benzenesulfonate salt of claim 2 , wherein Step 2 comprises reacting compound 11 with trimethylsilylchloride in a polar protic solvent.
4 . The benzenesulfonate salt of claim 3 , wherein the polar protic solvent is selected from methanol, ethanol, and isopropanol.
5 . The benzenesulfonate salt of claim 2 , wherein the reaction is carried out at a temperature from about 40° C. to about 60° C.
6 . The benzenesulfonate salt of claim 2 , wherein the process further comprises Step 1: converting compound 10 to compound 11:
7 . The benzenesulfonate salt of claim 6 , wherein in Step 1 compound 10 is reacted with a base and acetonitrile in a polar aprotic solvent to form compound 11.
8 . The benzenesulfonate salt of claim 7 , wherein the polar aprotic solvent is selected from tetrahydrofuran, ethyl acetate, acetone, and dimethylsulfoxide.
9 . The benzenesulfonate salt of claim 7 , wherein the base is potassium bis(trimethylsilyl)amide.
10 . The benzenesulfonate salt of claim 6 , wherein the reaction is carried out at a temperature less than about 10° C.
11 . The benzenesulfonate salt of claim 1 , wherein in Step 3 compound 12 is reacted with reagent A in an ether solvent to form compound 1.
12 . The benzenesulfonate salt of claim 11 , wherein the ether solvent is selected from anisole and diethyl ether.
13 . The benzenesulfonate salt of claim 1 , wherein the reaction is carried at a temperature from about 120° C. to about 160° C.
14 . The benzenesulfonate salt of claim 1 , wherein the process further comprises reacting compound 1 with benzenesulfonic acid in the presence of a polar aprotic solvent and an ether solvent.
15 . A benzenesulfonate salt of compound 1:
prepared by a process comprising:
converting compound 12 to compound 1:
wherein compound 12 is formed by reacting compound 11:
with trimethylsilylchloride in a polar protic solvent, and
reacting compound 1 with benzenesulfonic acid in the presence of a polar aprotic solvent and an ether solvent.
16 . The benzenesulfonate salt of claim 15 , wherein the polar aprotic solvent is selected from acetonitrile, ethyl acetate, and tetrahydrofuran.
17 . The benzenesulfonate salt of claim 15 , wherein the ether solvent is selected from anisole and diethyl ether, preferably wherein the ether solvent is anisole.Join the waitlist — get patent alerts
Track US2021214305A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.